|
|
||||||||
AJP - Cell Physiology, Vol 271, Issue 1 C304-C311, Copyright © 1996 by American Physiological Society
ARTICLES |
H. W. Lee, L. Smith, G. R. Pettit and J. Bingham Smith
Department of Pharmacology and Toxicology, School of Medicine, University of Alabama at Birmingham 35294, USA.
We show that bryostatin 1 (Bryo) rapidly produces an inactive, incompetent 76-kDa form of protein kinase C-alpha (PKC-alpha) in the LLC-MK2 line of renal epithelial cells. Bryo, like phorbol 12-myristate 13-acetate (PMA), acutely activated PKC, as indicated by autophosphorylation and translocation of PKC-alpha, the predominant PMA-sensitive isoform expressed by the cells. Bryo concomitantly increased the 32P labeling of 80-kDa PKC-alpha by autophosphorylation and produced a 76-kDa form of PKC-alpha that lacked detectable 32P. The 76-kDa form was in the particulate rather than the cytosolic fraction, which suggests that it was produced from activated kinase. Alkaline phosphatase treatment of immunoprecipitated PKC-alpha converted the 80-kDa form to 76 kDa, but it had no effect on the mobility of the 76-kDa form, suggesting that it was not phosphorylated. Pulse-chase labeling of PKC-alpha with [35S]Met/Cys indicated that there is a precursor-product relationship between the 80- and 76-kDa forms, respectively. Inhibition of protein synthesis had no effect on the production of 76-kDa PKC-alpha by Bryo. PMA also produced 76-kDa PKC-alpha but was less potent and efficacious than Bryo. Bryo produced a more rapid loss of 80-kDa PKC-alpha protein and total Ca(2+)- and phospholipid-dependent PKC activity than PMA. The 76-kDa form is inactive and incompetent because it lacked detectable 32P under conditions that strongly autophosphorylated the 80-kDa form. We suggest that dephosphorylation predisposes PKC to proteolysis, and greater production of the 76-kDa form explains the more efficient downregulation of the kinase by Bryo vs. PMA.
This article has been cited by other articles:
![]() |
D. Rabah, S. Grant, C. Ma, and D. H. Conrad Bryostatin-1 Specifically Inhibits In Vitro IgE Synthesis J. Immunol., November 1, 2001; 167(9): 4910 - 4918. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vrana and S. Grant Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade Blood, April 1, 2001; 97(7): 2105 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Lorenzo, K. Bogi, K. M. Hughes, M. Beheshti, D. Bhattacharyya, S. H. Garfield, G. R. Pettit, and P. M. Blumberg Differential Roles of the Tandem C1 Domains of Protein Kinase C {{delta}} in the Biphasic Down-Regulation Induced by Bryostatin 1 Cancer Res., December 1, 1999; 59(24): 6137 - 6144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Mullin, J. A. Kampherstein, K. V. Laughlin, C. E. K. Clarkin, R. D. Miller, Z. Szallasi, B. Kachar, A. P. Soler, and D. Rosson Overexpression of protein kinase C-delta increases tight junction permeability in LLC-PK1 epithelia Am J Physiol Cell Physiol, August 1, 1998; 275(2): C544 - C554. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Lorenzo, K. Bogi, P. Acs, G. R. Pettit, and P. M. Blumberg The Catalytic Domain of Protein Kinase Cdelta Confers Protection from Down-regulation Induced by Bryostatin 1 J. Biol. Chem., December 26, 1997; 272(52): 33338 - 33343. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Lee, L. Smith, G. R. Pettit, and J. B. Smith Bryostatin 1 and Phorbol Ester Down-Modulate Protein Kinase C-alpha and -epsilon via the Ubiquitin/Proteasome Pathway in Human Fibroblasts Mol. Pharmacol., March 1, 1997; 51(3): 439 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Lee, L. Smith, G. R. Pettit, A. Vinitsky, and J. B. Smith Ubiquitination of Protein Kinase C-alpha and Degradation by the Proteasome J. Biol. Chem., August 30, 1996; 271(35): 20973 - 20976. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, L. Smith, M. R. Johnson, K. Wang, R. B. Diasio, and J. B. Smith Activation of Protein Kinase C Induces Nuclear Translocation of RFX1 and Down-regulates c-myc via an Intron 1 X Box in Undifferentiated Leukemia HL-60 Cells J. Biol. Chem., October 6, 2000; 275(41): 32227 - 32233. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |